CRWV Insider Filing: RSU Vesting and 10b5-1 Sales on 09/30/2025
Rhea-AI Filing Summary
McBee Brannin, Chief Development Officer of CoreWeave, Inc. (CRWV), reported multiple transactions dated 09/30/2025. The filing shows vesting and settlement of restricted stock units (RSUs) and several sales executed under a Rule 10b5-1 trading plan adopted on May 20, 2025 to satisfy tax withholding from RSU settlements. Specific non-derivative sales include 57,903 shares at a weighted average price of $139.44 and multiple other lots with weighted-average prices ranging from $133.61 to $142.63.
The report also records acquisitions/vests of RSUs totaling 121,119 units (11,739 and 109,380) and conversions/holdings of Class B common stock that are convertible into Class A shares. Post-transaction beneficial ownership figures are reported across direct and indirect holdings, including substantial indirect Class B-based economic exposure shown in Table II.
Positive
- Sales executed under a Rule 10b5-1 plan (adopted May 20, 2025), indicating preplanned transactions
- Sales were used to satisfy tax withholding from RSU settlements rather than opportunistic large-scale liquidation
- RSU awards and vesting schedule disclosed, with first tranches on March 31 and June 30, 2025
Negative
- Material share sales reported on 09/30/2025, including 57,903 shares at a weighted average of $139.44
- Multiple subsequent sales across price ranges up to $142.63, reducing direct holdings
- Complex ownership structure with numerous trusts and indirect holdings, which may complicate investor transparency
Insights
Insider executed Rule 10b5-1 sales tied to RSU vesting; multiple holdings remain.
The filing documents that sales were made under a Rule 10b5-1 plan adopted on May 20, 2025, indicating preplanned disposition timing for some shares rather than ad hoc insider selling. The sales were primarily to satisfy tax withholding obligations from RSU settlements.
The report shows both direct and indirect ownership across trusts and family vehicles, and continuing large converted/Class B exposures are recorded in Table II, which may preserve long-term economic interest despite the sales.
RSU vesting and settlement visible; multiple tranches and deferred settlement noted.
The filing lists RSU awards of 11,739 and 109,380 units that vested or were settled on 09/30/2025 and earlier tranches referenced (first tranches vesting on March 31 and June 30, 2025). Some vested shares were settled following a compensation committee-approved deferral.
Sales to cover tax withholding are explicitly disclosed, and weighted-average sale prices for lots are provided in footnotes, demonstrating standard compensation-related liquidity rather than an undisclosed exit.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 11,739 | $0.00 | -- |
| Exercise | Restricted Stock Units | 109,380 | $0.00 | -- |
| Conversion | Class B Common Stock | 100,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 150,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 11,739 | $0.00 | -- |
| Exercise | Class A Common Stock | 109,380 | $0.00 | -- |
| Sale | Class A Common Stock | 57,903 | $139.44 | $8.07M |
| Conversion | Class A Common Stock | 100,000 | $0.00 | -- |
| Conversion | Class A Common Stock | 150,000 | $0.00 | -- |
| Sale | Class A Common Stock | 200 | $134.156 | $27K |
| Sale | Class A Common Stock | 400 | $135.008 | $54K |
| Sale | Class A Common Stock | 40,187 | $136.7781 | $5.50M |
| Sale | Class A Common Stock | 19,676 | $137.7483 | $2.71M |
| Sale | Class A Common Stock | 15,638 | $138.6123 | $2.17M |
| Sale | Class A Common Stock | 10,715 | $139.6204 | $1.50M |
| Sale | Class A Common Stock | 10,221 | $140.7747 | $1.44M |
| Sale | Class A Common Stock | 2,523 | $141.5942 | $357K |
| Sale | Class A Common Stock | 440 | $142.4373 | $63K |
| Sale | Class A Common Stock | 300 | $134.156 | $40K |
| Sale | Class A Common Stock | 600 | $135.008 | $81K |
| Sale | Class A Common Stock | 60,281 | $136.7781 | $8.25M |
| Sale | Class A Common Stock | 29,514 | $137.7483 | $4.07M |
| Sale | Class A Common Stock | 23,456 | $138.6122 | $3.25M |
| Sale | Class A Common Stock | 16,074 | $139.6204 | $2.24M |
| Sale | Class A Common Stock | 15,330 | $140.7747 | $2.16M |
| Sale | Class A Common Stock | 3,785 | $141.5942 | $536K |
| Sale | Class A Common Stock | 660 | $142.4373 | $94K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.61 to $134.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 6 through 13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.63 to $135.35, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.23 to $137.22, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.23 to $138.22, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.23 to $139.22, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.23 to $140.21, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.23 to $141.21, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.23 to $142.22, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.24 to $142.63, inclusive. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. The reported securities are directly held of record by the reporting person's minor child. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors. The reported securities are directly held by the reporting person's spouse. The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary. The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.